Inventiva S.A. (IVA)

About Inventiva S.A.

Inventiva SA is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases with unmet medical needs.

As of November 3, 2026, Inventiva S.A. (IVA) stock surged to $4.04, up 5.61% (+$0.22) versus the previous close. On the day, shares have traded between $3.78 and $4.17. That puts IVA in the lower third of its 52-week range of $2.82 to $7.29. Inventiva S.A. carries a market capitalization of roughly $862.26 million, with about 2.67 million shares changing hands.

Latest IVA news

• Inventiva (IVA) vs. CRSP and MDGL: Can Lanifibranor’s Phase 3 Trial Unlock 62% Upside?Yahoo Finance· Oct 28, 9:13 AM ET
• 3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Aheadmarketbeat.com· Oct 10, 10:35 AM ET
• Inventiva to Present Scientific Abstracts at AASLD The Liver Meeting® 2026Yahoo Finance· Oct 6, 4:05 PM ET
• Inventiva (IVA): How Much Is One Make-or-Break Readout Really Worth?Yahoo Finance· Oct 4, 3:26 PM ET
• Inventiva Eyes Q4 2026 Phase III MASH Data as Lanifibranor Nears Key Testmarketbeat.com· Oct 4, 1:02 AM ET
• European Equities Traded in the US as American Depositary Receipts Lower in Tuesday TradingYahoo Finance· Sep 29, 11:07 AM ET
• Inventiva (IVA) Q2 2026 Earnings Call Transcriptfool.com· Sep 29, 10:00 AM ET
• Inventiva SA (IVEVF) (H1 2026) Earnings Call Highlights: Lanifibranor Nears Phase 3 Readout ...Yahoo Finance· Sep 28, 3:00 PM ETIVEVF

Source: Yahoo Finance RSS · Updated November 3, 2026

Want IVA headlines, alerts and AI research in one place? Create a free account →

• $IVA $431.3M in Rezdiffra sales in one quarter, up 50% YoY. Hats off to $MDGL for opening this market for MASH patients. This is why I’m excited for $IVA. Doctors are already looking for MASH and prescribing an oral treatment. Imagine a strong NATiV3 readout landing in that ma…

  @Jyoudoit· Nov 3, 7:47 AM ET

• Breaking 🚨 $IVA Inventiva listed 15 new job openings on LinkedIn today. Not suggesting this means the data are positive. Just an interesting development worth keeping an eye on. DYOR. NFA.

  @Jyoudoit· Nov 2, 5:13 PM ET

• $IVA data imminent lets go

  @Bovan· Nov 2, 12:09 PM ET· Bullish

• @Daemeke I believe $IVA gets good results. I think they should get Share Price appreciation. It's an ADR so it sometimes has weird share prices (and corrections) so it becomes a difficult predictor in many cases (we've seen it drop a buck to correct the US price and th…

  @BioRich· Oct 31, 9:58 AM ET· Bullish

• $IVA closed the week at $3.65 (-1.6% w/w, -2.1% Friday), below the 50-day SMA ($3.82) and below the 200-day ($4.88). RSI14 53.8. Support $2.82, resistance $3.87 (20-day range, top). Broad market sell-off on Friday. New hub updated: https://www.merlintrader.com/inventiva-iva-st…

  @Merlintrader· Oct 31, 5:24 AM ET

Source: Stocktwits. User posts are opinions, not verified facts. See what's trending →